Disease ⇒ Dyslipidemia {40000533}
| Type: | Disease |
|---|---|
| Definition: | Dyslipidemia |
| Parent: | [ ] |
| Initialisation date: | 2022-01-12 |
|---|---|
| Other Terms: | [ ] |
| MedDra ID: | [ ] |
|---|---|
| MedDra Level: | [ ] |
| ICD: | [ ] |
| Category: | [ ] |
| Zone: | [ ] |
| Mechanism: | [ ] |
Notes:
[ ]
Shared Notes
- [1.1]
- Prob+BBR superior to BBR or Prob alone in improving postprandial total cholesterol (pTC) and low-density lipoprotein cholesterol (pLDLc) levels with decrement of multiple species of postprandial lipidomic metabolites after 3 months follow-up.
- This effect was linked to the changes of fecal Bifidobacterium breve level responding to BBR alone or Prob+BBR treatment.
- Four fadD genes encoding long-chain acyl-CoA synthetase > identified in the genome of this B. breve strain, and transcriptionally activated by BBR.
- The activation of fadD by BBR could enhance FFA import and mobilization in B. breve and diliminish the intraluminal lipids for absorption to mediate the effect of Prob+BBR on PL.